hydralazine has been researched along with liraglutide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, S; Ichikawa, D; Inoue, K; Kamijo-Ikemori, A; Kimura, K; Nagai, Y; Natsuki, Y; Ogura, Y; Ohata, K; Shibagaki, Y; Sugaya, T; Tanabe, J; Watanabe, S; Yamada, S | 1 |
| Hoshino, S; Inoue, K; Kamijo-Ikemori, A; Kimura, K; Watanabe, M; Yamada, S | 1 |
2 other study(ies) available for hydralazine and liraglutide
| Article | Year |
|---|---|
Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats.
Topics: Animals; Citrate (si)-Synthase; Comorbidity; Diabetes Mellitus, Type 2; Electron Transport Complex IV; Gene Expression Regulation; Hydralazine; Insulin; Liraglutide; Male; Muscle Strength; Muscle, Skeletal; Obesity; Rats; Rats, Sprague-Dawley | 2022 |
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Hydralazine; Hypertension; Insulins; Liraglutide; Male; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2022 |